Status:

COMPLETED

Safety and Efficacy of Patient Controlled Analgesia Using the Sublingual Sufentanil Tablet System (SSTS) in a Fast Track Rehabilitation Program After Total Knee Arthroplasty

Lead Sponsor:

University Hospital, Ghent

Conditions:

Postoperative Pain

Eligibility:

All Genders

40-75 years

Phase:

PHASE4

Brief Summary

The sufentanil sublingual tablet system (SSTS) is an innovative patient-controlled analgesia (PCA) device for the management of acute moderate to severe postoperative pain in hospital settings in adul...

Detailed Description

Total knee arthroplasty is one of the most common major procedures performed today with a significant impact on health care budgets. Fast track rehabilitation programmes are being developed to control...

Eligibility Criteria

Inclusion

  • Male and female patients between 40-75 years old
  • Able to give consent
  • Scheduled of elective knee arthroplasty with a fast rehabilitation program
  • Able to understand PCA principle and capable to operate SSTS device

Exclusion

  • Outside age range
  • Contra indication for anti-inflammatory drugs
  • Revision total knee arthroplasty
  • history of substance abuse,
  • pregnancy,lactation
  • severe hepatic impairment (INR\>1,5 and/or AST/ALT above x3 highest normal value),
  • sleep apnea (documented by sleep laboratory study),
  • severe chronic kidney disease (eGFR\<30 mL/min/1.73 m2),
  • severe and very severe COPD (GOLD III and IV)
  • opioid tolerance (use of \>15mg oral morphine equivalent per day within the past 3 months),
  • chronic pain conditions necessitating gabapentinoids, steroids or anti-inflammatory drugs
  • hypersensitivity to sufentanil
  • significant respiratory depression (need for outpatient supplemental oxygen therapy),
  • participation in another clinical trial

Key Trial Info

Start Date :

May 26 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 19 2021

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT04432428

Start Date

May 26 2020

End Date

September 19 2021

Last Update

December 6 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Ghent

Ghent, Oost-Vlaanderen, Belgium, 9000